DexCom, Inc. (DXCM)

Price$72.86

Value ScoreC

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)6.87%

Price vs S&P 500 (4W)20.22%

VGM Score58.44

Market Capitalization$28.11B

P/E Ratio (Annual)33.62x

All Metrics

P/CF (Annual)19.51x

Book Value / Share (Quarterly)$7.66

P/TBV (Annual)9.68x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.01%

Cash Flow / Share (Quarterly)$3.70

Price vs S&P 500 (YTD)1.62%

Gross Margin (TTM)63.43%

Net Profit Margin (TTM)19.31%

EPS (TTM)$2.31

10-Day Avg Trading Volume5.80M

EPS Excl Extra (TTM)$2.31

Revenue Growth (5Y)19.33%

EPS (Annual)$2.06

ROI (Annual)20.70%

Gross Margin (Annual)62.09%

Net Profit Margin (5Y Avg)13.55%

Cash / Share (Quarterly)$6.26

P/E Basic Excl Extra (TTM)30.22x

Revenue Growth QoQ (YoY)15.05%

EPS Growth (5Y)9.54%

P/E Normalized (Annual)33.62x

ROA (Last FY)13.19%

Revenue Growth TTM (YoY)16.15%

EBITD / Share (TTM)$3.21

ROE (5Y Avg)22.13%

Operating Margin (TTM)21.45%

Cash Flow / Share (Annual)$2.80

P/B Ratio9.51x

P/B Ratio (Quarterly)8.17x

Net Income / Employee (Annual)$76,000

EV / Revenue (TTM)5.87x

Net Interest Coverage (TTM)978.00x

ROA (TTM)13.39%

EPS Growth QoQ (YoY)95.94%

EV / EBITDA (TTM)21.89x

EPS Incl Extra (Annual)$2.06

Current Ratio (Annual)1.88x

Quick Ratio (Quarterly)1.61x

3-Month Avg Trading Volume5.16M

52-Week Price Return-15.02%

EV / Free Cash Flow (Annual)26.26x

P/E Incl Extra (TTM)30.22x

Revenue / Employee (TTM)$438,000

Tangible BV / Share (Quarterly)$7.45

P/S Ratio (Annual)6.03x

Asset Turnover (Annual)0.74x

52-Week High$89.98

Operating Margin (5Y Avg)15.05%

EPS Excl Extra (Annual)$2.06

CapEx CAGR (5Y)12.81%

Tangible BV CAGR (5Y)56.65%

26-Week Price Return14.79%

Quick Ratio (Annual)1.56x

13-Week Price Return3.07%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)1.95x

Enterprise Value$28.29B

Revenue / Share Growth (5Y)20.19%

Asset Turnover (TTM)0.69x

Book Value / Share Growth (5Y)8.47%

Revenue / Employee (Annual)$423,800

Inventory Turnover (Annual)3.02x

Pretax Margin (Annual)23.35%

Cash / Share (Annual)$5.19

3-Month Return Std Dev39.64%

Gross Margin (5Y Avg)64.50%

Net Income / Employee (TTM)$84,600

EBITDA CAGR (5Y)30.97%

EBITDA Interim CAGR (5Y)37.00%

ROE (Last FY)30.46%

Net Interest Coverage (Annual)32.41x

EPS Basic Excl Extra (Annual)$2.06

P/FCF (TTM)19.67x

Receivables Turnover (TTM)4.29x

EV / Free Cash Flow (TTM)19.79x

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$2.31

Receivables Turnover (Annual)4.20x

ROI (TTM)20.01%

P/S Ratio (TTM)5.84x

Pretax Margin (5Y Avg)16.89%

Revenue / Share (Annual)$11.50

Tangible BV / Share (Annual)$6.95

Forward P/E26.60x

Free OCF CAGR (5Y)31.25%

Price vs S&P 500 (52W)-39.39%

P/E Ratio (TTM)30.22x

EPS Growth TTM (YoY)77.45%

Year-to-Date Return9.78%

5-Day Price Return-2.68%

EPS Normalized (Annual)$2.06

ROA (5Y Avg)8.29%

Net Profit Margin (Annual)17.94%

Month-to-Date Return-1.19%

Cash Flow / Share (TTM)$1.28

EBITD / Share (Annual)$2.87

EPS Growth (3Y)37.23%

Operating Margin (Annual)19.56%

LT Debt / Equity (Annual)0.45x

P/CF (TTM)15.77x

ROI (5Y Avg)11.71%

P/E Excl Extra (TTM)30.22x

LT Debt / Equity (Quarterly)0.42x

EPS Basic Excl Extra (TTM)$2.31

P/TBV (Quarterly)8.40x

P/B Ratio (Annual)9.43x

Inventory Turnover (TTM)2.86x

Pretax Margin (TTM)24.98%

Book Value / Share (Annual)$7.14

Price vs S&P 500 (13W)-5.18%

Net Margin Growth (5Y)-8.86%

Beta1.41x

P/FCF (Annual)26.10x

Revenue / Share (TTM)$12.24

ROE (TTM)33.83%

52-Week Low$54.11

vGradeC

gGradeB

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.56est. 0.48

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.22

4.24

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
DXCMDexCom, Inc.	C	B	C	$72.86
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53
GMEDGLOBUS MEDICAL INC	B	A	C	$80.00

About

DexCom manufactures continuous glucose monitoring systems that provide an alternative to traditional blood glucose testing for diabetes management. The company's CGM technology integrates with insulin pumps from Insulet and Tandem to enable automated insulin delivery. Products are distributed through medical equipment distributors and retail pharmacies.